TechNavio says Increased Outsourcing Activities Will Positively Affect Profit Margins in the Global Oncology Biosimilars Market by 2018
London, 17 November 2014 – TechNavio, a tech-focused research firm has published a new report on the Global Oncology Biosimilars Market, which is expected to grow at a CAGR of 29.87 percent from 2014-2018. A good percentage of this growth is due to a growing number of biopharmaceutical patent expiries expected in the near…
